AI assistant
Sending…
PAVmed Inc. — Director's Dealing 2022
Dec 3, 2022
35221_dirs_2022-12-02_c6815654-990c-43af-a8b7-f91e828fa484.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Lucid Diagnostics Inc. (LUCD)
CIK: 0001799011
Period of Report: 2022-11-30
Reporting Person: PAVmed Inc. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-30 | Common stock | J | 1145086 | $1.8383 | Acquired | 40253331 | Direct |
| 2022-11-30 | Common Stock | J | 197656 | $2.7826 | Acquired | 40450987 | Direct |
| 2022-11-30 | Common Stock | J | 221952 | $2.4780 | Acquired | 40672939 | Direct |
| 2022-11-30 | Common Stock | J | 331210 | $1.6606 | Acquired | 41004149 | Direct |
| 2022-11-30 | Common Stock | J | 1479326 | $1.8383 | Acquired | 42483475 | Direct |
Footnotes
F1: Issuance of common stock by the Issuer to the Reporting Person in satisfaction of a commercial agreement.
More from PAVmed Inc.
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 1
Annual Report
2026
Apr 30
Earnings Release
2026
Mar 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Feb 24
Regulatory Filings
2026
Feb 17
Capital/Financing Update
2026
Feb 4
Regulatory Filings
2026
Jan 23